Valuation: CODON

Market Cap 7L 7L 6L 5L 10.39L 6.84Cr 10.64L 72.79L 29.01L 3.66Cr 27.37L 26.79L 12Cr P/E 2021
-4.36x
P/E 2022 -0.3x
Enterprise Value 15.84L 17.58L 14.64L 13.23L 25.04L 16Cr 25.65L 1.75Cr 69.92L 8.83Cr 65.97L 64.57L 28Cr EV / Sales 2021
3.94x
EV / Sales 2022 1.09x
Free-Float
35.8%
Yield 2021 *
-
Yield 2022 -
Manager TitleAgeSince
Chief Executive Officer 62 16/01/2020
Investor Relations Contact - -
Director TitleAgeSince
Chairman - 29/04/2022
Director/Board Member - 07/07/2010
Director/Board Member 82 12/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%+1.36%+45.38%+140.47% 1,27600Cr
-0.13%+1.48%+44.67%+90.43% 68TCr
+0.37%+0.05%+31.00%+112.84% 52TCr
+0.02%+1.52%+39.21%+69.76% 39TCr
-0.59%-2.11%+61.83%+45.16% 36TCr
-1.29%-1.13%+27.54%+58.29% 31TCr
+0.09%-0.91%+3.19%+37.72% 29TCr
+0.62%-2.17%+38.31%+75.12% 25TCr
-0.67%-2.72%+38.49%+123.56% 21TCr
Average +0.04%+0.00%+36.62%+83.71% 48TCr
Weighted average by Cap. +0.47%+0.56%+39.50%+97.22%

Financials

2021 2022
Net sales 98.03L 1.09Cr 90.57L 81.87L 1.55Cr 102.01Cr 1.59Cr 11Cr 4.33Cr 55Cr 4.08Cr 4Cr 173.86Cr 62.41L 69.25L 57.66L 52.13L 98.62L 65Cr 1.01Cr 6.91Cr 2.75Cr 35Cr 2.6Cr 2.54Cr 110.69Cr
Net income -93.22L -1.03Cr -86.12L -77.86L -1.47Cr -97Cr -1.51Cr -10Cr -4.11Cr -52Cr -3.88Cr -3.8Cr -165.33Cr -1.7Cr -1.88Cr -1.57Cr -1.42Cr -2.68Cr -176.7Cr -2.75Cr -19Cr -7.49Cr -95Cr -7.07Cr -6.92Cr -301.15Cr
Net Debt -3L -3L -3L -2L -5L -3.05Cr -5L -32.44L -12.93L -1.63Cr -12.2L -11.94L -5.2Cr 9L 10.29L 9L 8L 14.65L 9.65Cr 15.01L 1.03Cr 40.91L 5.17Cr 38.6L 37.78L 16Cr
Logo CODON
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
Employees
-